Recent advances in understanding T cell activation and exhaustion during HBV infection
Chronic hepatitis B virus (HBV) infection remains a major public health concern globally, and T cell responses are widely believed to play a pivotal role in mediating HBV clearance. Accordingly, research on the characteristics of HBV-specific T cell responses, from activation to exhaustion, has adva...
Gespeichert in:
Veröffentlicht in: | Virologica Sinica 2023-12, Vol.38 (6), p.851-859 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 859 |
---|---|
container_issue | 6 |
container_start_page | 851 |
container_title | Virologica Sinica |
container_volume | 38 |
creator | Wang, Lu Zeng, Xiaoqing Wang, Zida Fang, Ling Liu, Jia |
description | Chronic hepatitis B virus (HBV) infection remains a major public health concern globally, and T cell responses are widely believed to play a pivotal role in mediating HBV clearance. Accordingly, research on the characteristics of HBV-specific T cell responses, from activation to exhaustion, has advanced rapidly. Here, we summarize recent developments in characterizing T cell immunity in HBV infection by reviewing basic and clinical research published in the last five years. We provide a comprehensive summary of the mechanisms that induce effective anti-HBV T cell immunity, as well as the latest developments in understanding T cell dysfunction in chronic HBV infection. Furthermore, we briefly discuss current novel treatment strategies aimed at restoring anti-HBV T cell responses.
•Recent progresses made in understanding the mechanisms of inducing anti-HBV T immunity have been systematically reviewed, shedding light on critical aspects of HBV clearance.•The latest basic and clinical developments in understanding T cell dysfunction in chronic HBV infection have been comprehensively summarized.•Novel treatment strategies that aim to restore anti-HBV T cell responses and have shown promising effects in preclinical or clinical trials have been discussed. |
doi_str_mv | 10.1016/j.virs.2023.10.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2880821243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1995820X2300130X</els_id><sourcerecordid>2880821243</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-3a23499d49bdd726da81106b52967621d19fefa1f7c64bc871c66336c59da9c3</originalsourceid><addsrcrecordid>eNp9kE9LwzAYxoMobk6_gAfp0Utr_rRpAl50qBMGgozhLaRJqhlbOpO26Lc3dVM8ecqb532eh-QHwDmCGYKIXq2y3vqQYYhJFDIIywMwRpwXKcPw5fDPPAInIawgpJgRcgxGpGSUMlSMwfLZKOPaROpeOmVCYl3SOW18aKXT1r0mi0SZ9TqRqrW9bG3jkrhIzMeb7ML3VXd-8M1ulzFcGzWIp-ColutgzvbnBCzu7xbTWTp_enic3sxTlUPYpkRiknOuc15pXWKqJUMI0qrAnJYUI414bWqJ6lLRvFKsRIpSQqgquJZckQm43NVuffPemdCKjQ3Dc6UzTRcEZgwyjHBOohXvrMo3IXhTi623G-k_BYJiwClWYsApBpyDFnHG0MW-v6s2Rv9GfvhFw_XOYOIne2u8CMqaCFJbH0kI3dj_-r8AHuuG8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2880821243</pqid></control><display><type>article</type><title>Recent advances in understanding T cell activation and exhaustion during HBV infection</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Lu ; Zeng, Xiaoqing ; Wang, Zida ; Fang, Ling ; Liu, Jia</creator><creatorcontrib>Wang, Lu ; Zeng, Xiaoqing ; Wang, Zida ; Fang, Ling ; Liu, Jia</creatorcontrib><description>Chronic hepatitis B virus (HBV) infection remains a major public health concern globally, and T cell responses are widely believed to play a pivotal role in mediating HBV clearance. Accordingly, research on the characteristics of HBV-specific T cell responses, from activation to exhaustion, has advanced rapidly. Here, we summarize recent developments in characterizing T cell immunity in HBV infection by reviewing basic and clinical research published in the last five years. We provide a comprehensive summary of the mechanisms that induce effective anti-HBV T cell immunity, as well as the latest developments in understanding T cell dysfunction in chronic HBV infection. Furthermore, we briefly discuss current novel treatment strategies aimed at restoring anti-HBV T cell responses.
•Recent progresses made in understanding the mechanisms of inducing anti-HBV T immunity have been systematically reviewed, shedding light on critical aspects of HBV clearance.•The latest basic and clinical developments in understanding T cell dysfunction in chronic HBV infection have been comprehensively summarized.•Novel treatment strategies that aim to restore anti-HBV T cell responses and have shown promising effects in preclinical or clinical trials have been discussed.</description><identifier>ISSN: 1995-820X</identifier><identifier>EISSN: 1995-820X</identifier><identifier>DOI: 10.1016/j.virs.2023.10.007</identifier><identifier>PMID: 37866815</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Hepatitis B ; Hepatitis B virus ; Hepatitis B virus (HBV) ; Hepatitis B, Chronic - drug therapy ; Humans ; Immune therapy ; Immunity, Cellular ; T cell ; T-Lymphocytes</subject><ispartof>Virologica Sinica, 2023-12, Vol.38 (6), p.851-859</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Publishing services by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-3a23499d49bdd726da81106b52967621d19fefa1f7c64bc871c66336c59da9c3</citedby><cites>FETCH-LOGICAL-c400t-3a23499d49bdd726da81106b52967621d19fefa1f7c64bc871c66336c59da9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27913,27914</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37866815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Lu</creatorcontrib><creatorcontrib>Zeng, Xiaoqing</creatorcontrib><creatorcontrib>Wang, Zida</creatorcontrib><creatorcontrib>Fang, Ling</creatorcontrib><creatorcontrib>Liu, Jia</creatorcontrib><title>Recent advances in understanding T cell activation and exhaustion during HBV infection</title><title>Virologica Sinica</title><addtitle>Virol Sin</addtitle><description>Chronic hepatitis B virus (HBV) infection remains a major public health concern globally, and T cell responses are widely believed to play a pivotal role in mediating HBV clearance. Accordingly, research on the characteristics of HBV-specific T cell responses, from activation to exhaustion, has advanced rapidly. Here, we summarize recent developments in characterizing T cell immunity in HBV infection by reviewing basic and clinical research published in the last five years. We provide a comprehensive summary of the mechanisms that induce effective anti-HBV T cell immunity, as well as the latest developments in understanding T cell dysfunction in chronic HBV infection. Furthermore, we briefly discuss current novel treatment strategies aimed at restoring anti-HBV T cell responses.
•Recent progresses made in understanding the mechanisms of inducing anti-HBV T immunity have been systematically reviewed, shedding light on critical aspects of HBV clearance.•The latest basic and clinical developments in understanding T cell dysfunction in chronic HBV infection have been comprehensively summarized.•Novel treatment strategies that aim to restore anti-HBV T cell responses and have shown promising effects in preclinical or clinical trials have been discussed.</description><subject>Hepatitis B</subject><subject>Hepatitis B virus</subject><subject>Hepatitis B virus (HBV)</subject><subject>Hepatitis B, Chronic - drug therapy</subject><subject>Humans</subject><subject>Immune therapy</subject><subject>Immunity, Cellular</subject><subject>T cell</subject><subject>T-Lymphocytes</subject><issn>1995-820X</issn><issn>1995-820X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LwzAYxoMobk6_gAfp0Utr_rRpAl50qBMGgozhLaRJqhlbOpO26Lc3dVM8ecqb532eh-QHwDmCGYKIXq2y3vqQYYhJFDIIywMwRpwXKcPw5fDPPAInIawgpJgRcgxGpGSUMlSMwfLZKOPaROpeOmVCYl3SOW18aKXT1r0mi0SZ9TqRqrW9bG3jkrhIzMeb7ML3VXd-8M1ulzFcGzWIp-ColutgzvbnBCzu7xbTWTp_enic3sxTlUPYpkRiknOuc15pXWKqJUMI0qrAnJYUI414bWqJ6lLRvFKsRIpSQqgquJZckQm43NVuffPemdCKjQ3Dc6UzTRcEZgwyjHBOohXvrMo3IXhTi623G-k_BYJiwClWYsApBpyDFnHG0MW-v6s2Rv9GfvhFw_XOYOIne2u8CMqaCFJbH0kI3dj_-r8AHuuG8w</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Wang, Lu</creator><creator>Zeng, Xiaoqing</creator><creator>Wang, Zida</creator><creator>Fang, Ling</creator><creator>Liu, Jia</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202312</creationdate><title>Recent advances in understanding T cell activation and exhaustion during HBV infection</title><author>Wang, Lu ; Zeng, Xiaoqing ; Wang, Zida ; Fang, Ling ; Liu, Jia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-3a23499d49bdd726da81106b52967621d19fefa1f7c64bc871c66336c59da9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Hepatitis B</topic><topic>Hepatitis B virus</topic><topic>Hepatitis B virus (HBV)</topic><topic>Hepatitis B, Chronic - drug therapy</topic><topic>Humans</topic><topic>Immune therapy</topic><topic>Immunity, Cellular</topic><topic>T cell</topic><topic>T-Lymphocytes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Lu</creatorcontrib><creatorcontrib>Zeng, Xiaoqing</creatorcontrib><creatorcontrib>Wang, Zida</creatorcontrib><creatorcontrib>Fang, Ling</creatorcontrib><creatorcontrib>Liu, Jia</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Virologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Lu</au><au>Zeng, Xiaoqing</au><au>Wang, Zida</au><au>Fang, Ling</au><au>Liu, Jia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances in understanding T cell activation and exhaustion during HBV infection</atitle><jtitle>Virologica Sinica</jtitle><addtitle>Virol Sin</addtitle><date>2023-12</date><risdate>2023</risdate><volume>38</volume><issue>6</issue><spage>851</spage><epage>859</epage><pages>851-859</pages><issn>1995-820X</issn><eissn>1995-820X</eissn><abstract>Chronic hepatitis B virus (HBV) infection remains a major public health concern globally, and T cell responses are widely believed to play a pivotal role in mediating HBV clearance. Accordingly, research on the characteristics of HBV-specific T cell responses, from activation to exhaustion, has advanced rapidly. Here, we summarize recent developments in characterizing T cell immunity in HBV infection by reviewing basic and clinical research published in the last five years. We provide a comprehensive summary of the mechanisms that induce effective anti-HBV T cell immunity, as well as the latest developments in understanding T cell dysfunction in chronic HBV infection. Furthermore, we briefly discuss current novel treatment strategies aimed at restoring anti-HBV T cell responses.
•Recent progresses made in understanding the mechanisms of inducing anti-HBV T immunity have been systematically reviewed, shedding light on critical aspects of HBV clearance.•The latest basic and clinical developments in understanding T cell dysfunction in chronic HBV infection have been comprehensively summarized.•Novel treatment strategies that aim to restore anti-HBV T cell responses and have shown promising effects in preclinical or clinical trials have been discussed.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37866815</pmid><doi>10.1016/j.virs.2023.10.007</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1995-820X |
ispartof | Virologica Sinica, 2023-12, Vol.38 (6), p.851-859 |
issn | 1995-820X 1995-820X |
language | eng |
recordid | cdi_proquest_miscellaneous_2880821243 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Hepatitis B Hepatitis B virus Hepatitis B virus (HBV) Hepatitis B, Chronic - drug therapy Humans Immune therapy Immunity, Cellular T cell T-Lymphocytes |
title | Recent advances in understanding T cell activation and exhaustion during HBV infection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T09%3A17%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20in%20understanding%20T%20cell%20activation%20and%20exhaustion%20during%20HBV%20infection&rft.jtitle=Virologica%20Sinica&rft.au=Wang,%20Lu&rft.date=2023-12&rft.volume=38&rft.issue=6&rft.spage=851&rft.epage=859&rft.pages=851-859&rft.issn=1995-820X&rft.eissn=1995-820X&rft_id=info:doi/10.1016/j.virs.2023.10.007&rft_dat=%3Cproquest_cross%3E2880821243%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2880821243&rft_id=info:pmid/37866815&rft_els_id=S1995820X2300130X&rfr_iscdi=true |